O50 Monitoring adherence to subcutaneous biologics for IBD care using digital technology – a NHSX pr...
O50 Monitoring adherence to subcutaneous biologics for IBD care using digital technology – a NHSX proof of concept study following COVID-19
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
IntroductionDuring and following the COVID-19 pandemic, there has been a major expansion of self-administered subcutaneous biologics for the management of inflammatory bowel disease. These agents are more difficult to monitor since patients do not need to attend the Biologics infusion unit and there is no audit trail to confirm administration of th...
Alternative Titles
Full title
O50 Monitoring adherence to subcutaneous biologics for IBD care using digital technology – a NHSX proof of concept study following COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2828941770
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2828941770
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2023-BSG.49
